Keywords: متفورمین; Cationic lipid; Metformin; Biguanide; Intrinsic antitumor activity; TRAIL; Nanoparticles
مقالات ISI ترجمه شده متفورمین
مقالات ISI متفورمین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: متفورمین; Metformin; SCFA; Cancer; Butyrate producing taxa; Microbiome;
Keywords: متفورمین; Bone morphogenetic protein (BMP); Granulosa cells; Metformin; Smad and steroidogenesis; ActRII; activin type-II receptor; ALK; activin receptor-like kinase; AMPK; AMP-activated protein kinase; BMP; bone morphogenetic protein; BMPRII; BMP type-II receptor;
Keywords: متفورمین; Turnip; Brassica rapa; Metformin; Interaction; Liver; Rat;
Keywords: متفورمین; BCR; Belgian cancer registry; IMA; intermutualistic agency; NNSS; national number for social security; ICD; international classification of disease; DDD; defined daily dose; OS; overall survival; CSS; cancer specific survival; HR; hazard ratio; CI; confid
Keywords: متفورمین; Apoptosis; Metformin; Oxidative stress; Rapamycin; Testicular torsion/detorsion;
Keywords: متفورمین; AMT; active motor threshold; cTBS; continuous theta burst stimulation; EMG; electromyogram; GA; gestational age; GDM; gestational diabetes mellitus; HOMA-IR; homeostatic model assessment for insulin resistance; HPA; hypothalamic-pituitary-adrenal; SI1mV;
Keywords: متفورمین; Streptozotocin (PubChem CID: 29327); 2,4-Dinitrophenylhydrazine (PubChem CID: 3772977); Digitonin (PubChem CID: 6474107); Streptomycin sulfate (PubChem CID: 19648); 5,5â²-Dithiobis-2-nitrobenzoic acid (PubChem CID: 6254); Titanium (IV) oxysulfate-sulfuri
Keywords: متفورمین; Metformin; Endothelium; Nitric oxide synthase; Obesity; Zucker;
Keywords: متفورمین; ADMA; asymmetric dimethylarginine; cAMP; cyclic AMP; CVD; cardiovascular disease; CT; chemotherapy; DOX; doxorubicin; DDAH; dimethylarginine diaminohydrolase; eNOS; endothelial nitric oxide synthase; FSK; forskolin; HCY; homocysteine; HTRF; homogenous tim
Keywords: متفورمین; Type 2 diabetes mellitus-tuberculosis coinfection; Metformin; Lactic acidosis;
Keywords: متفورمین; Exercise; Metformin; Oxygen consumption; Type 2 diabetes mellitus (T2DM);
Keywords: متفورمین; Metformin; Mode of action; Diabetes; Cancer; Polycystic ovarian syndrome; Alzheimer's disease;
Keywords: متفورمین; MDA; malondialdehyde; SOD; superoxide dismutase; TNF-α; tumor necrosis factor-alpha; DM; diabetes mellitus; MWM; Morris water maze; STZ; streptozotocin; T1DM; type 1 diabetes mellitus; T2DM; type 2 diabetes mellitus; Safranal; Diabetes; Learning and memo
Keywords: متفورمین; aPKC; atypical protein kinase C; CBP; CREB binding protein; ChREBP; carbohydrate response element-binding protein; CREB; cAMP response element-binding protein; CRTC2; CREB-regulated transcription coactivator 2; FA; fatty acid; GIPR; glucose-dependent insu
Keywords: متفورمین; Metformin; Macrophage polarization; Palmitate; Inflammation; AMPK;
Keywords: متفورمین; Zebrafish; Pharmaceuticals; Metformin; Biomarkers; Endocrine disruption;
Keywords: متفورمین; Bile acids; UHPLC-MS; Quantification; Metformin; db/db mice;
Keywords: متفورمین; CAT; Catalase; DAI; Disease activity index; DSS; Dextran sulfate sodium; ELISA; Enzyme linked immunoassay; IBD; Inflammatory bowel disease; IL; Interleukin; α-LA; Alpha-lipoic acid; MDA; Malondialdehyde; NF-κB; Nuclear factor-kappa-B; PBS-BSA; Phosphate
Keywords: متفورمین; AMD; age-related macular degeneration; Ap5A; di(adenosine)â5-penta-phosphate; ATP synthase; FoF1-ATP synthase; DR; diabetic retinopathy; ETC; electron transport chain; MTF; Metformin: OS, outer segment; PUFA; polyunsaturated fatty acids; ROI; reactive o
Keywords: متفورمین; Pharmaceutical pollutants; Degradation; Metformin; P25; Radical hydroxyl; Photocatalysis; Sunlight irradiation; Solar reactor;
Keywords: متفورمین; Indicators; Pharmaceutically active compounds; Metformin; Guanylurea;
Keywords: متفورمین; Metformin; Chitosan; Intrapocket dental film; Periodontitis; Rat model; Alveolar bone loss;
Keywords: متفورمین; insulin; glyburide; GDM; metformin;
Keywords: متفورمین; bone regeneration; mesenchymal stromal cells; metformin; organic cation transporters; osteogenesis; stem cells; umbilical cord;
Keywords: متفورمین; Gestational diabetes; Pregnancy; CNKI; Metformin; Ethnicity; Race;
Keywords: متفورمین; dipeptidyl peptidase-4 inhibitor; drug-drug interactions; metformin; pharmacokinetics; teneligliptin;
Keywords: متفورمین; Diabetes mellitus; Gliclazide; Glucose; Lipids; Metformin; Oxidative stress;
Keywords: متفورمین; chronic kidney disease; CKD-MBD; high bone turnover; metformin; renal fibrosis; vascular calcification;
Keywords: متفورمین; T2DM; Type 2 diabetes mellitus; NG; normal glucose concentration; HG; high glucose concentration; mTORC; mammalian target of rapamycin complex; GLUT; glucose transporters; LKB1; Liver kinase B1; AMPK; AMP-activated protein kinase; AKT; Protein kinase B; A
Keywords: متفورمین; Apoptosis; Caspase-3; Cell cycle arrest; Doxorubicin; Metformin; p21 expression;
Keywords: متفورمین; Depressive symptoms; Diabetes; Repositioning; Systematic review; Meta-analysis; Meta-regression; Inflammation; Insulin resistance; Pioglitazone; Metformin;
Keywords: متفورمین; Metformin; Coagulation; Haemostasis; Biocompatibility;
Keywords: متفورمین; Childhood obesity; Prevention plus; Motivational interviewing; Cardiometabolic risks; Metformin; Behavioral interventions;
Keywords: متفورمین; Oral cancer; Head and neck cancer; Mouth neoplasm; Hydroxymethylglutaryl-CoA reductase inhibitors; Metformin; Anti-inflammatory agents; Non-steroidal; Statins;
Keywords: متفورمین; Translational geroscience; Healthspan; Longevity; Aging; Rapamycin; Metformin; mTOR; Companion animals;
Keywords: متفورمین; Metformin; LC-QQQ-MS; Clinical samples; Plasma concentrations; Forensics; Lactic acidosis; Post mortem;
Keywords: متفورمین; diabetes mellitus; metformin; skin cancer; Taiwan; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; NHI; National Health Insurance; NMSC; nonmelanoma skin cancer; PS; propensity score; UV; ultrav
Keywords: متفورمین; Metformin; Steady-state level; Patient-factors; Therapeutic dosage; Type-2 diabetes mellitus;
Keywords: متفورمین; Metformin; Cancer; Diabetes; Glucose-lowering therapies;
Keywords: متفورمین; Bromocriptine; Metformin; Prolactinoma; Refractory pituitary adenoma; AMPK; Adenosine monophosphate activated protein kinase; DA; Dopamine agonist; MRI; Magnetic resonance imaging; PRL; Prolactin;
Keywords: متفورمین; Metformin; Off-label use; Pregnancy outcome; Malformation; Birth defects; Spontaneous abortion;
Keywords: متفورمین; Metformin; Waste water; HILIC; SPE; pH-value;
Keywords: متفورمین; Metformin; Pancreatic stellate cells (PSCs); Sonic hedgehog (SHH); Tumor angiogenesis; Gemcitabine; Chemosensitization;
Keywords: متفورمین; Niosomes; Metformin; Glipizide; Diabetes treatment;
Keywords: متفورمین; Tissue engineering; Bone regeneration; Metformin; Tricalcium phosphate; Hydroxyapatite; Dental pulp stem cells;
Keywords: متفورمین; Alogliptin; Advanced amplitude modulation; Derivative ratio; Metformin; Mean centering, Ratio difference;
Keywords: متفورمین; airway epithelium; glucose; metformin; Pseudomonas aeruginosa; Staphylococcus aureus; ASL; airway surface liquid; CF; cystic fibrosis; GLUT; glucose transporter; MRSA; methicillin-resistant Staphylococcus aureus; PPAR; peroxisome proliferator-activated re
Keywords: متفورمین; Diabetes; Cancer; Insulin; Metformin; Oral anti-diabetes drugs;
Keywords: متفورمین; Metformin; Guanylurea; Biodegradation; Enrichment cultures; Biodegradation kinetics;